|
June 22,
2004 CONGRESS
QUESTIONS NIH ON PRIORITIES NIH
needs to take a hard look at how it divides its budget between
emerging scientific
opportunities and public health needs, according to congressional
questioners at a June 2 hearing held by the House Energy and Commerce’s
Subcommittee on Health. “What we want is the most effective, state-of-the-art NIH
in the 21st century that gets the biggest bang for the taxpayers'
buck," said Rep. Joe Barton, R-Texas, who also said he would
push for complete congressional reauthorization of NIH in 2004. Although Barton acknowledged
that Congress is partially to blame for the proliferation of
NIH institutes over the past few decades,
he and others at the hearing said NIH’s current structure
poses problems for interdisciplinary research and keeps the NIH
director from setting overarching budget and research priorities. Rep. Henry Waxman, D-Calif,
an outspoken critic of recent inquiries into NIH’s peer-review process, cautioned against too much
congressional interference, saying that some “congressmen
have given into the temptation to substitute their own scientific
judgment” when it comes to NIH operations. Testifying at the hearing
with several of his institute heads, NIH Director Elias Zerhouni
said NIH’s successes “have
changed the landscape of the diseases we have to deal with” but
agreed that NIH needs to expand trans-institute priority reviews
like the recent Roadmap project (see HABIT, October 28, 2003) and “invest
in modern decision making support systems.” The hearing focused
on how NIH institutes decide to allocate their funding and how
responsive the institutes are to public health
concerns raised by the public and congressional members. Subcommittee
Chair Michael Biliraki, R-Fla., acknowledged that the process was
complicated but also said that the issue has drawn public scrutiny “because
NIH lacks transparency in many of its decision-making procedures.” Zerhouni, along with NIAID Director Anthony Fauci, M.D., NCI Director
Andrew von Eschenbach, M.D., and NIDA director Nora Volkow, M.D.,
gave short summaries of their budget processes and how they receive
outside input on spending. Fauci warned that legislating structural
changes for NIH might deprive the institutes of their flexibility,
although he did support efforts to give more power to the NIH director. To watch a Webcast of the hearing, go here. |
|
||||||